Interestingly, this association was maintained in the subgroup of stage I NSCLC patients, who had not received adjuvant treatment after surgery, suggesting a clear prognostic role for NKX2–1 mRNA expression. Here, NKX2-1 is linked to non-small cell lung carcinoma.